M Mavissakalian

438 total citations
8 papers, 328 citations indexed

About

M Mavissakalian is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, M Mavissakalian has authored 8 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Psychology, 6 papers in Experimental and Cognitive Psychology and 1 paper in Pharmacology. Recurrent topics in M Mavissakalian's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers), Mental Health Research Topics (6 papers) and Child and Adolescent Psychosocial and Emotional Development (3 papers). M Mavissakalian is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers), Mental Health Research Topics (6 papers) and Child and Adolescent Psychosocial and Emotional Development (3 papers). M Mavissakalian collaborates with scholars based in United States. M Mavissakalian's co-authors include J M Perel, James M. Perel, Rolf G. Jacob, Larry Michelson, Samuel M. Turner, Robert S. Dealy and Mary Sue Hamann and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Comprehensive Psychiatry.

In The Last Decade

M Mavissakalian

8 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Mavissakalian United States 8 250 245 75 57 35 8 328
Yvon-Jacques Lavallée Canada 7 201 0.8× 211 0.9× 55 0.7× 38 0.7× 31 0.9× 8 333
Seda Şengün United Kingdom 5 274 1.1× 222 0.9× 67 0.9× 31 0.5× 54 1.5× 14 373
Rita T. McDonald United States 5 156 0.6× 300 1.2× 94 1.3× 51 0.9× 75 2.1× 6 361
J. Zohar Israel 5 111 0.4× 190 0.8× 48 0.6× 78 1.4× 81 2.3× 12 321
Giulio Barzega Italy 10 175 0.7× 342 1.4× 103 1.4× 33 0.6× 127 3.6× 17 419
Elena Di Nasso Italy 9 91 0.4× 216 0.9× 83 1.1× 24 0.4× 47 1.3× 16 312
James Broatch United States 5 125 0.5× 361 1.5× 67 0.9× 41 0.7× 116 3.3× 5 440
Lynn Y. Martin United States 7 229 0.9× 202 0.8× 58 0.8× 18 0.3× 37 1.1× 9 331
F L'Heureux United States 7 128 0.5× 313 1.3× 91 1.2× 36 0.6× 82 2.3× 7 392
Cheryl Rubenstein United States 9 154 0.6× 432 1.8× 90 1.2× 21 0.4× 125 3.6× 9 490

Countries citing papers authored by M Mavissakalian

Since Specialization
Citations

This map shows the geographic impact of M Mavissakalian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mavissakalian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mavissakalian more than expected).

Fields of papers citing papers by M Mavissakalian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mavissakalian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mavissakalian. The network helps show where M Mavissakalian may publish in the future.

Co-authorship network of co-authors of M Mavissakalian

This figure shows the co-authorship network connecting the top 25 collaborators of M Mavissakalian. A scholar is included among the top collaborators of M Mavissakalian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mavissakalian. M Mavissakalian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mavissakalian, M. (1995). Long-term treatment of anxiety disorders. Biological Psychiatry. 37(9). 594–594. 44 indexed citations
2.
Mavissakalian, M & J M Perel. (1992). Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. American Journal of Psychiatry. 149(8). 1053–1057. 22 indexed citations
3.
Mavissakalian, M & James M. Perel. (1992). Clinical Experiments in Maintenance and Discontinuation of Imipramine Therapy in Panic Disorder With Agoraphobia. Archives of General Psychiatry. 49(4). 318–318. 57 indexed citations
4.
Mavissakalian, M & Mary Sue Hamann. (1992). DSM-III personality characteristics of panic disorder with agoraphobia patients in stable remission. Comprehensive Psychiatry. 33(5). 305–309. 11 indexed citations
5.
Mavissakalian, M. (1990). The Relationship Between Panic Disorder/Agoraphobia and Personality Disorders. Psychiatric Clinics of North America. 13(4). 661–684. 22 indexed citations
6.
Mavissakalian, M, et al.. (1987). Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. American Journal of Psychiatry. 144(6). 785–787. 30 indexed citations
7.
Mavissakalian, M, Samuel M. Turner, Larry Michelson, & Rolf G. Jacob. (1985). Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II. American Journal of Psychiatry. 142(5). 572–576. 93 indexed citations
8.
Mavissakalian, M & J M Perel. (1985). Imipramine in the treatment of agoraphobia: dose-response relationships. American Journal of Psychiatry. 142(9). 1032–1036. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026